GBP5 and cranioectodermal dysplasia: The second study demonstrated a CeD / no CeD diagnosis based on transcriptomic profiles of duodenal biopsies which revealed a potential biomarker subset consisting of CXCL10, GBP5, IFI27, IFNG, and UBD [90].